MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 31 filers reported holding MILESTONE PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,248 | -44.8% | 1,693 | -49.3% | 0.00% | – |
| Q2 2023 | $9,510 | -12.9% | 3,337 | +20.4% | 0.00% | – |
| Q1 2023 | $10,922 | -46.8% | 2,772 | -46.5% | 0.00% | – |
| Q4 2022 | $20,532 | -33.8% | 5,185 | +56.2% | 0.00% | – |
| Q3 2022 | $31,000 | +416.7% | 3,320 | +226.8% | 0.00% | – |
| Q2 2022 | $6,000 | -14.3% | 1,016 | -1.5% | 0.00% | – |
| Q4 2021 | $7,000 | +133.3% | 1,031 | +113.5% | 0.00% | – |
| Q2 2021 | $3,000 | -96.2% | 483 | -96.4% | 0.00% | – |
| Q1 2021 | $78,000 | -20.4% | 13,499 | -7.8% | 0.00% | – |
| Q4 2020 | $98,000 | -19.0% | 14,646 | -11.6% | 0.00% | – |
| Q3 2020 | $121,000 | +137.3% | 16,560 | +22.7% | 0.00% | – |
| Q2 2020 | $51,000 | +104.0% | 13,499 | 0.0% | 0.00% | – |
| Q1 2020 | $25,000 | – | 13,499 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alta Fundamental Advisers LLC | 1,176,189 | $3,646,186 | 1.74% |
| Bleichroeder LP | 1,326,085 | $4,110,864 | 1.01% |
| BML Capital Management, LLC | 272,500 | $844,750 | 0.78% |
| VR Adviser, LLC | 2,208,812 | $6,847,317 | 0.72% |
| Lion Point Capital, LP | 450,207 | $1,395,642 | 0.62% |
| PVG ASSET MANAGEMENT CORP | 15,405 | $47,755 | 0.32% |
| Affinity Asset Advisors, LLC | 335,068 | $1,038,711 | 0.29% |
| RTW INVESTMENTS, LP | 3,256,102 | $10,093,916 | 0.21% |
| Ikarian Capital, LLC | 462,828 | $1,434,767 | 0.17% |
| Boxer Capital, LLC | 309,007 | $957,922 | 0.05% |